InvestorsHub Logo
Followers 13
Posts 185
Boards Moderated 0
Alias Born 01/17/2017

Re: None

Thursday, 11/14/2019 12:02:11 PM

Thursday, November 14, 2019 12:02:11 PM

Post# of 704122
Spoke with DI yesterday.

Have spoken with him numerous times and he has always been upbeat, respectful, and engaged.

SAP "draft" is in all regulatory agencies' hands. This draft is solid and they are awaiting responses. Some may respond faster than others (*cough* EU *cough*) and some may not respond at all. It will then be in NWBO hands to weigh the costs and benefits to waiting longer to hear back from say.. FDA. For example, if NICE has given the green light to go ahead and unblind with SAP, but still radio silence from FDA, what should NWBO do? Wait another month for FDA, or unblind now and go with Europe? The decision is in NWBO hands~ getting SAP approval from all agencies does not seem to be an obligatory step in the process, however, positive responses surely will give them more confidence in unblinding the trial for OS.

Regardless, all patients still alive in the trial are past the 4 year mark. The long tail is there. One of the next things we will be hearing is the company is in Data Lock. They have investors waiting to give more money if more time is needed, however any subsequent raise will be small, like the last one. 30 day period where NWBO cannot sell more shares ends next week.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News